Linked Life Data

3584735

Source:http://linkedlifedata.com/resource/pubmed/id/3584735

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1987-7-2
pubmed:abstractText
The results of recent large, prospective clinical trials have established that the reduction of plasma total and low density lipoprotein cholesterol concentrations in certain hyperlipidemic patients reduced their risk for developing symptomatic cardiovascular disease. Attention has now been turned to both defining which individuals should be treated and how best to treat those patients. Utilizing the concepts of human lipid, lipoprotein, and apolipoprotein metabolism that have evolved over the past 20 years, the metabolism of the plasma lipoproteins can be effectively modulated in the majority of hyperlipoproteinemic patients. In addition to summarizing human lipoprotein metabolism, this article outlines a step-by-step approach to the treatment of hyperlipoproteinemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0731-5724
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
157-63
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Definition and management of hyperlipoproteinemia.
pubmed:publicationType
Journal Article